Cordis Names Roberto Patarca as Chief Medical Officer

DUBLIN, Ohio, April 30, 2020 — Cordis, a Cardinal Health company, appoints Roberto Patarca, M.D., Ph.D. as Chief Medical Officer, effective April 13, 2020. Dr. Patarca brings more than 15 years of industry experience in global medical affairs and clinical research. His primary focus has been in clinical studies, education, product safety, quality assurance, field work and strategic planning. He has been a clinician and clinical trialist, basic scientist and bio analyst (molecular to cellular diagnostics), and a well published editor of biomedical journals.

“Dr. Patarca brings a great blend of strategic clarity and deep relationships with cardiovascular key opinion leaders,” said Cordis President Patrick Holt. “He is an experienced global leader and brings an entrepreneurial, hands on spirit that will help us continue to build our 60-year heritage by focusing on quality, innovation and education.”

As Cordis Chief Medical Officer, Dr. Patarca will lead Cordis Clinical, Medical, Clinical Education and Training and customer Key Opinion Leader engagement functions.

“I am excited to join Cordis, a company of many firsts in interventional devices, and to foster its impact as a trusted and valued partner of healthcare professionals and systems, professional societies, regulatory bodies and academia to advance cardiovascular medicine for the benefit of patients worldwide.” said Dr. Patarca.

About Roberto Patarca, M.D.
Dr. Patarca was the Medical Strategy Lead and Medical Affairs Director, Antibacterials and Antifungals for Hospital Systems at Merck & Co. Inc. In addition, Dr. Patarca has served as a member of advisory committees to two U.S. Secretaries of Department of Health and Human Services and worked in academia at University of Miami School of Medicine/Jackson Memorial Hospital and Harvard Medical School.

Roberto has deep therapeutic experience in numerous areas, including interventional cardiology, electrophysiology, immunology, infectious diseases, and oncology. As a result, he has longstanding scientific & educational partnerships globally with cardiovascular opinion leaders.

Roberto received his Master of Science in Biology from Central University of Venezuela, Ph.D. in Experimental Pathology from Harvard University, and M.D. from University of Miami School of Medicine.

About Cardinal Health
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company enhances supply chain efficiency for clinically proven medical products, pharmaceuticals and cost-effective solutions. To combat prescription drug misuse, the Cardinal Health Foundation and its education partners created Generation Rx, a national drug prevention education and awareness program. The Foundation actively supports an array of other solutions, including efforts to reduce opioid prescribing, promote drug take back and safe disposal and expand collaborative community work.

Cardinal Health is backed by nearly 100 years of experience with operations in nearly 46 countries. For more information, visit cardinalhealth.com.